Olga Ab

Olga Ab

Company: ImmunoGen

Job title: Product Lead IMGN151 and IMGC936


Next-generation ADCs (IMGN151 & IMGC936) 3:30 pm

• Innovated next-generation ADCs • IMGN151 is a next generation FRα-targeting ADC engineered to include multiple technological innovations to maximize the potential clinical benefit for patients with a broad range of target expression • IMGC936 is an investigational ADAM9-targeting ADC, comprised of a high-affinity humanized monoclonal antibody site-specifically coupled to DM21Read more

day: day 1 track 1 pm

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.